The Palladium™ COVID Test System is a PCR-based test based on novel, proprietary technology. It integrates sample prep, PCR amplification and detection in a closed system for unparalleled ease-of-use. There is absolutely no sample prep required - it’s as easy as sample in and results out in approximately 90 minutes .*
*Not FDA cleared. Not yet available for sale.
No sample prep, minimal training required. With “sample-in, results-out” technology, manual sample prep errors are virtually eliminated.
Wi-fi enabled cloud-based data collection allows monitoring and detection of disease trends and outbreaks to reduce human and economic impact.
High test accuracy reduces false positive absenteeism and false negative risk of spread for workers. Protects long term care residents from unnecessary quarantine. Allows appropriate and timely patient management.
EUA submission for COVID-19 test expected October 2021
Integrated Nano-Technologies, Inc. is committed to providing fast, accurate test results that improve biological identification for a variety of applications. Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has developed a robust, on-site diagnostic platform replacing traditionally time-intensive and complex lab processes.
The Palladium™ System provides rapid, molecular (PCR) test results in an automated closed system combining sample preparation, nucleic acid amplification, and detection. With its straightforward “Sample In, Results Out” test process, manual processing errors are minimized to ensure reliable and accurate test results. The Palladium System enables any user with minimal training to conduct infectious disease testing for a multitude of applications. INT’s innovative platform has gained grant support from numerous governmental agencies and global foundations, to support a robust, high-performance system that meets emerging needs in human healthcare, food processing, veterinary, biothreat, and other applications.